Works matching IS 15588211 AND DT 2013 AND VI 8 AND IP 1
Results: 11
Management of the New Patient with CML in Chronic Phase.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 37, doi. 10.1007/s11899-012-0151-0
- By:
- Publication type:
- Article
What Do We Do with Chronic Lymphocytic Leukemia with 17p Deletion?
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 81, doi. 10.1007/s11899-012-0143-0
- By:
- Publication type:
- Article
Lenalidomide Alone and in Combination for Chronic Lymphocytic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 7, doi. 10.1007/s11899-012-0146-x
- By:
- Publication type:
- Article
Monoclonal B Cell Lymphocytosis-What Does It Really Mean?
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 52, doi. 10.1007/s11899-012-0144-z
- By:
- Publication type:
- Article
Role of Epigenetics in Chronic Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 28, doi. 10.1007/s11899-012-0152-z
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 43, doi. 10.1007/s11899-012-0149-7
- By:
- Publication type:
- Article
GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 22, doi. 10.1007/s11899-012-0142-1
- By:
- Publication type:
- Article
Signal Transduction in the Chronic Leukemias: Implications for Targeted Therapies.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 71, doi. 10.1007/s11899-012-0150-1
- By:
- Publication type:
- Article
CARs in Chronic Lymphocytic Leukemia - Ready to Drive.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 60, doi. 10.1007/s11899-012-0145-y
- By:
- Publication type:
- Article
Ibrutinib (PCI-32765), the First BTK (Bruton's Tyrosine Kinase) Inhibitor in Clinical Trials.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 1, doi. 10.1007/s11899-012-0147-9
- By:
- Publication type:
- Article
Targeting Chronic Myeloid Leukemia Stem Cells.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 14, doi. 10.1007/s11899-012-0148-8
- By:
- Publication type:
- Article